| Title |
Author |
Type |
Date |
Words |
| Efficacy of Neoadjuvant Chemotherapy with Epirubicin and Cyclophosphamide and Weekly Paclitaxel and Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Carcinoma: A Real-World Study. |
Zhang, Mengmeng; Li, Ling; Zhang, Shiyong; Zhu, Wenlong; Yang, Senguo; Di, Guangsheng; Ma, Xiaoxia; |
Report |
Aug 31, 2020 |
5592 |
| Huaier Granule Combined with Tegafur Gimeracil Oteracil Potassium Promotes Stage IIb Gastric Cancer Prognosis and Induces Gastric Cancer Cell Apoptosis by Regulating Livin. |
Qi, Jing; Xie, Fu-juan; Liu, Sheng; Yao, Cheng-yu; Liu, Wei-hang; Cai, Gao-qiang; Liao, Guo-qing |
|
Jul 31, 2020 |
5376 |
| Paclitaxel, Imatinib and 5-Fluorouracil Increase the Unbound Fraction of Flucloxacillin In Vitro. |
Stolte, Maximilian; Ali, Weaam; Janis, Janne; Gessner, Andre'; Najjar, Nahed El- |
Report |
Jun 1, 2020 |
10728 |
| Low-Dose Decitabine Assists Human Umbilical Cord-Derived Mesenchymal Stem Cells in Protecting Cells via the Modulation of the Macrophage Phenotype in Type 2 Diabetic Mice. |
Xue, Jing; Cheng, Yu; Hao, Haojie; Gao, Jieqing; Yin, Yaqi; Yu, Songyan; Zou, Junyan; Liu, Jiejie; Z |
|
Apr 30, 2020 |
8362 |
| High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. |
Fushimi, Atsushi; Tabei, Isao; Fuke, Azusa; Okamoto, Tomoyoshi; Takeyama, Hiroshi |
|
Mar 1, 2020 |
3666 |
| A Remarkable Remission: Treating HMA Refractory Transforming MDS with Single-Agent Low-Dose Cytarabine Leading to an Ongoing Six-Year OS. |
Palmer, David; Jones, Lydia |
|
Mar 1, 2020 |
2182 |
| Possible new principle for cancer therapy. |
|
|
Mar 31, 2018 |
672 |
| Re: Nanotechnology in Urology. |
Jin, S.; Labhasetwar, V. |
Editorial |
Mar 1, 2018 |
251 |
| Low-dose rituximab cut infection risk in rheumatoid arthritis. |
Splete, Heidi |
|
Feb 15, 2018 |
336 |
| Cardiotoxicity associated with 5-flurouracil--A case series. |
Das, Jisha S; Panicker, Naveen Kumar |
Case study |
Jan 1, 2018 |
1543 |
| Practical Immunohistochemistry in Neoplastic Pathology of the Gastrointestinal Tract, Liver, Biliary Tract, and Pancreas. |
Wang, Hanlin L.; Kim, Christopher J.; Koo, Jamie; Zhou, Wendi; Choi, Eunice K.; Arcega, Ramir; Chen, |
Report |
Sep 1, 2017 |
22024 |
| Combining two different chemotherapy agents with platinum analogs as induction and consolidation regimes in nonsmall cell lung carcinoma. |
Khan, Mohsin; Siddiqui, Shahid |
Report |
Jul 1, 2017 |
2309 |
| Dermatological adverse effects of chemotherapeutic agents: experience from a tertiary centre. |
Rather, Parvaiz Anwar; Mir, M. Hussain; Kaul, Sandeep; Roshan, Vikas; Mathews, Jilu; Sharma, Bandu |
Report |
Jun 26, 2017 |
2882 |
| Silymarin reduces severity of radiotherapy-induced oral mucositis. |
Tester, Jodie |
Report |
Jun 1, 2017 |
585 |
| Establishment of patient-derived tumor xenograft (PDTX) models using samples from CT-guided percutaneous biopsy. |
Zhuang, Y.-P.; Zhu, Y.-P.; Wang, H.-Y.; Sun, L.; Zhang, J.; Hao, Y.-P.; Wang, L. |
Report |
Jun 1, 2017 |
3929 |
| Metronomic Chemotherapy in Triple-Negative Metastatic Breast Cancer: The Future Is Now? |
Cazzaniga, M.E.; Cortesi, L.; Ferzi, A.; Scaltriti, L.; Cicchiello, F.; Ciccarese, M.; Torre, S. Del |
Report |
Jan 1, 2017 |
4561 |
| The Landscape of Randomised Controlled Trials of Therapies in Breast Cancer in Low and Middle Income Countries. |
Lynch-Kelly, Katharine; Singer, Matthew; Williams, Norman R. |
|
Jan 1, 2017 |
3919 |
| Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway. |
Wu, Yang; Leng, Yan; Meng, Qingtao; Xue, Rui; Zhao, Bo; Zhan, Liying; Xia, Zhongyuan |
Report |
Jan 1, 2017 |
8235 |
| In Vitro Anticancer Effect of Gedunin on Human Teratocarcinomal (NTERA-2) Cancer Stem-Like Cells. |
Tharmarajah, Luxmiga; Samarakoon, Sameera Ranganath; Ediriweera, Meran Keshawa; Piyathilaka, Poorna; |
Report |
Jan 1, 2017 |
5765 |
| Platinum-Based Drugs Differentially Affect the Ultrastructure of Breast Cancer Cell Types. |
Bahlani, Shadia Al-; Dhahli, Buthaina Al-; Adawi, Kawther Al-; Nabhani, Abdurahman Al-; Kindi, Moham |
Report |
Jan 1, 2017 |
6565 |
| Safety and Efficacy of First-Line Treatments for Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Indirect Comparison. |
Zheng, Haofeng; Chen, Jialiang; Qiu, Wenhan; Lin, Sijie; Chen, Yanxiong; Liang, Guancan; Fang, Youqi |
Report |
Jan 1, 2017 |
5103 |
| Immune Thrombocytopenia in a Child with Neuroblastoma. |
Ikizoglu, Hasan Tarkan; Ayan, Inci; Tokat, Fatma; Tecimer, Tulay; Tekant, Gonca Topuzlu |
Case study |
Jan 1, 2017 |
2115 |
| Cardiac Nonmyocyte Cell Functions and Crosstalks in Response to Cardiotoxic Drugs. |
Gambardella, Jessica; Trimarco, Bruno; Iaccarino, Guido; Sorriento, Daniela |
Report |
Jan 1, 2017 |
8420 |
| Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials. |
Yu, Lixiu; Zhou, Ying; Yang, Yu; Lu, Furong; Fan, Yeqin |
Report |
Jan 1, 2017 |
6606 |
| Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. |
|
|
Dec 31, 2016 |
2862 |
| Neoplastic causes of nonacute facial paralysis: a review of 221 cases. |
Leonetti, John P.; Marzo, Sam J.; Anderson, Douglas A.; Sappington, Joshua M. |
Report |
Sep 1, 2016 |
2608 |
| Immune-modulating cancer drugs finally get some respect. |
Faloon, Chancellor |
|
Jun 1, 2016 |
4060 |
| Disease characteristics and survival outcomes of extragonadal primary germ cell tumour in two Canadian tertiary cancer centres. |
Ko, Jenny J.; Asif, Tehmina; Li, Haocheng; Alimohamed, Nimira; Nguyen, Phuong Thao; Heng, Daniel Y.C |
Report |
May 1, 2016 |
4521 |
| A study of coagulation profile in neoplastic conditions. |
Patel, Sarmishtha M.; Gupta, Swati; Patel, Mandakini M.; Mahadik, Juhi D.; Patel, Kinjal A.; Patel, |
Report |
Mar 1, 2016 |
3843 |
| ICON: improving care of human health using intelligent data mining. |
Kiruba, S. Arul; Pavithra, V.; Saranya, A.; Dharani, B. |
Report |
Feb 1, 2016 |
3464 |
| Hyaluronidases and hyaluronan synthases expression is inversely correlated with malignancy in lung/bronchial pre-neoplastic and neoplastic lesions, affecting prognosis. |
de Sa, V.K.; Rocha, T.P.; Moreira, A.L.; Soares, F.A.; Takagaki, T.; Carvalho, L.; Nicholson, A.G.; |
Report |
Nov 1, 2015 |
5070 |
| Resveratrol, quercetin could improve safety of cancer drug. |
|
Brief article |
Nov 1, 2015 |
172 |
| Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells. |
Kim, Kyung-Ho; Kim, Ji-Yun; Kwak, Jong-Hwan; Pyo, Suhkneung |
Report |
Aug 15, 2015 |
5910 |
| New cancer drugs can wake up sleeping killer T cells: frontline immune system fighters, often evaded by tumors, might now resume the attack. |
Seppa, Nathan |
|
Jul 11, 2015 |
1512 |
| Norcantharidin derivatives as inhibitors in the development of breast cancer drugs. |
Patel, Darshil M. |
Report |
Apr 1, 2015 |
519 |
| A New Way To Deliver Drugs. |
Vartak, Rasika |
|
Feb 22, 2015 |
579 |
| Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response. |
Satelli, Arun; Brownlee, Zachary; Mitra, Abhisek; Meng, Qing H.; Li, Shulin |
Report |
Jan 1, 2015 |
4915 |
| InnoPharma wins US FDA approval of Decitabine for Injection for treating myelodysplastic syndromes. |
|
|
Sep 1, 2014 |
157 |
| InnoPharma wins US FDA approval of Decitabine for Injection for treating myelodysplastic syndromes. |
|
|
Sep 1, 2014 |
153 |
| Correlations Between Cytogenetic and Molecular Monitoring Among Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Post Hoc Analyses of the Rationale and Insight for Gleevec High-Dose Therapy Study. |
Akard, Luke P.; Cortes, Jorge E.; Albitar, Maher; Goldberg, Stuart L.; Warsi, Ghulam; Wetzler, Meir; |
|
Sep 1, 2014 |
5040 |
| Relationship of inflammatory markers and pain in patients with head and neck cancer prior to anticancer therapy. |
Oliveira, K.G.; von Zeidler, S.V.; Lamas, A.Z.; de Podesta, J.R.V.; Sena, A.; Souza, E.D.; Lenzi, J. |
Report |
Jul 1, 2014 |
3306 |
| The joint effects of a chemotherapeutic agent and hematopoietic agent on stem cell production. |
Mouser, Christina L.; Antoniou, Eliana |
Report |
Mar 22, 2014 |
1614 |
| A phase I dose-escalation study of oral BR-DIM (bioresponse 3,3'- diindolylmethane) in castrate-resistant, non-metastatic prostate cancer. |
|
|
Dec 1, 2013 |
347 |
| Mechanisms of the anti-proliferative and anti-inflammatory effects of the herbal fixed combination STW 5 (Iberogast[R]) on colon adenocarcinoma (HT29) cells in vitro. |
Bonaterra, G.A.; Kelber, O.; Weisr, D.; Kinscherf, R. |
Report |
Jun 15, 2013 |
6390 |
| Complete response to low-dose sorafenib in a patient with metastatic renal cell carcinoma: A case report. |
Morita, Jun; Naoe, Michio; Ogawa, Yu; Nakasato, Takehiko; Sugahara, Motoko; Morita, Masashi; Fuji, K |
Clinical report |
May 1, 2013 |
2385 |
| Scientists in North saving young lives; Cancer drug dosages raised after research. |
|
|
Jan 17, 2013 |
728 |
| The down side of cancer salves. |
|
Brief article |
Oct 1, 2012 |
230 |
| Hodgkin's lymphoma with leptomeningeal involvement / Leptomeningeal Tutulumlu Hodgkin Lenfoma. |
Yildirim, Rahsan; Gundogdu, Mehmet; Erdem, Fuat; Kiki, Ilhami; Gundogdu, Betul |
Case study |
Sep 1, 2012 |
2361 |
| New immune-based cancer therapies. |
Klotter, Jule |
|
Aug 1, 2012 |
575 |
| Alternative therapeutic approach to various cancers with combinations of chemotherapeutic drugs or vitamin C and D-fraction. |
Konno, Sensuke; Alexander, Bobby; Choudhury, Muhammad |
Clinical report |
Aug 1, 2012 |
2010 |
| Sagent Pharmaceuticals Inc unveils Irinotecan Injection in single dose vials. |
|
|
May 18, 2012 |
147 |
| Sagent Pharmaceuticals Inc unveils Irinotecan Injection in single dose vials. |
|
|
May 18, 2012 |
133 |
| War on cancer. |
Moss, Ralph |
|
Apr 1, 2012 |
2168 |
| New set of nanoparticles 'may accurately deliver cancer drugs to tumours'. |
|
|
Jan 20, 2012 |
481 |
| War on Cancer: progress against chronic lymphocytic leukemia. |
Moss, Ralph |
|
Nov 1, 2011 |
2205 |
| Recommendations for the management of adult chronic myeloid leukaemia in South Africa. |
Louw, V.J.; Dreosti, L.; Ruff, P.; Jogessar, V.; Moodley, D.; Novitzky, N.; Patel, M.; Schmidt, A.; |
Disease/Disorder overview |
Nov 1, 2011 |
4783 |
| War on cancer: two new drugs emerge for melanoma. |
Moss, Ralph |
|
Oct 1, 2011 |
2311 |
| NanoSmart Pharmaceuticals opens new office, works on novel drug delivery platform. |
|
|
Sep 8, 2011 |
130 |
| Fast-track drugs. |
Klotter, Jule |
|
Aug 1, 2011 |
683 |
| Post-chemo brain. |
Klotter, Jule |
|
Aug 1, 2011 |
460 |
| Curcumin compound boosts head and neck cancer therapy. |
Dye, D. |
Brief article |
Aug 1, 2011 |
199 |
| Sagent Pharmaceuticals Inc unveils chemotherapy drug gemcitabine for Injection, USP. |
|
|
Jul 26, 2011 |
112 |
| Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids. |
Salminen, Kaisa A.; Meyer, Achim; Jerabkova, Lenka; Korhonen, Laura E.; Rahnasto, Minna; Juvonen, Ri |
Report |
Apr 15, 2011 |
4961 |
| The case of the uncontrolled nausea and vomiting. |
Eisenberg, Seth |
|
Apr 1, 2011 |
308 |
| Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. |
Chanmahasathien, Wisinee; Ampasavate, Chadarat; Greger, Harald; Limtrakul, Pornngarm |
Report |
Jan 15, 2011 |
5854 |
| Crizotinib shows promise against some types of NSCLC. |
McBride, Deborah |
Brief article |
Jan 1, 2011 |
270 |
| Recent developments in the early diagnosis and management of multiple sclerosis. |
Ross, Amy Perrin; Thrower, Ben W. |
Report |
Dec 1, 2010 |
8621 |
| Breast cancer. |
|
Disease/Disorder overview |
Dec 1, 2010 |
9220 |
| FDA delay of one drug causes 82,000 lost life-years. |
Faloon, William |
|
Nov 1, 2010 |
3988 |
| Journal abstracts: metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. |
|
|
Nov 1, 2010 |
311 |
| Bar raised in metastatic prostate Ca treatment. |
Freeman, Sara |
|
Nov 1, 2010 |
898 |
| In vitro and in vivo antitumor activity of Macrothelypteris torresiana and its acute/subacute oral toxicity. |
Huang, X.H.; Xiong, P.C.; Xiong, C.M.; Cai, Y.L.; Wei, A.H.; Wang, J.P.; Liang, X.F.; Ruan, J.L. |
Report |
Oct 1, 2010 |
5245 |
| New foe for advanced melanoma: drug offers hope to half of patients with deadly skin cancer. |
Seppa, Nathan |
Brief article |
Sep 25, 2010 |
306 |
| UK NICE does not recommend higher doses for Novartis' Glivec. |
|
|
Sep 16, 2010 |
147 |
| Agents show promise for basal cell carcinoma. |
Boschert, Sherry |
|
Sep 15, 2010 |
588 |
| Cellular assassin's surprise benefit; disabling killer protein might encourage repeated cancers. |
Saey, Tina Hesman |
|
Aug 28, 2010 |
455 |
| Sanofi-aventis gets FDA nod for Taxotere Injection Concentrate. |
|
|
Aug 5, 2010 |
199 |
| Bio-Path Holdings doses first patient in Phase I clinical trial of L-Grb-2 for acute leukemia. |
|
|
Jul 30, 2010 |
175 |
| Jury hears of inmate's final hours; WARDER TELLS HOW PRISONER FEARED HE'D BEEN GIVEN WRONG DOSAGE. |
|
|
Jul 15, 2010 |
492 |
| Man's horror end after cancer drug prescription error; PRISONER GIVEN WRONG DOSAGE OF POWERFUL CHEMOTHERAPY. |
|
|
Jul 14, 2010 |
918 |
| B.C. inorganic chemists meet in Squamish. |
Leznoff, Daniel |
|
Jul 1, 2010 |
302 |
| Good leukemia drug news. |
Seppa, Nathan |
Brief article |
Jan 2, 2010 |
106 |
| Neuroblastoma, a childhood nerve cancer, proves sensitive to drug: compound allows body's own tumor suppressor to do its job. |
Seppa, Nathan |
|
Dec 5, 2009 |
374 |
| Chakalaka-induced vasodilatation in patients with chronic myeloid leukaemia on tyrosine kinase inhibitors. |
Coetzee, Marius J.; Louw, Vernon J.; Gartrell, Kevin; Viljoen, Chris D. |
Report |
Dec 1, 2009 |
1441 |
| Does benefit always outweigh risk when a SERM is used to prevent primary breast cancer? |
Kaunitz, Andrew M. |
Report |
Nov 1, 2009 |
730 |
| Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. |
Guillen, Ponce; Carrato, Alfredo |
Clinical report |
Oct 1, 2009 |
1431 |
| How many women must be treated to avert one case? |
Joyner, Donald R. |
Clinical report |
Oct 1, 2009 |
576 |
| Anticancer drugs: no option but to outsource? |
Polastro, Enrico T.; Tulcinsky, Sonia |
|
Oct 1, 2009 |
2171 |
| Women with breast cancer lived significantly longer without their disease getting worse when treated with Germany's Bayer AG and Onyx Pharmaceuticals Inc's (Emeryville CA) cancer pill Nexavar, researchers said. |
|
Brief article |
Sep 28, 2009 |
249 |
| New treatment for mast cell cancer tumors: not without risks, but a good option for inoperable tumors in particular. |
Straus, Mary |
|
Aug 1, 2009 |
493 |
| Cancer drugs could help alcoholics. |
|
Brief article |
Jul 1, 2009 |
213 |
| Few cancer breakthroughs reported at major meeting. |
|
|
Jun 8, 2009 |
331 |
| Britain's healthcare cost-effectiveness watchdog has recommended Merck KGaA's drug Erbitux be used on the state health service for treating some colon cancer patients after surgery. |
|
Brief article |
Jun 8, 2009 |
219 |
| Smart pumps help limit infusion errors. |
Eisenberg, Seth |
Brief article |
Mar 1, 2009 |
279 |
| Cytotoxic therapies to feel the sting of generics: cytotoxic therapy, or chemotherapy as it is commonly known, has been the cornerstone of cancer treatment for many years and involves the use of drugs that are toxic to all cells--including those that are perfectly healthy. While relatively effective, this leads to the unpleasant side-effects commonly associated with cytotoxic treatment, such as vomiting, nausea, alopecia and fatigue. |
Dick, Matthew |
|
Mar 1, 2009 |
790 |
| 3-Hydrogenkwadaphnine, a novel diterpene ester from Dendrostellera lessertii, its role in differentiation and apoptosis of KG1 cells. |
Yazdanparast, Razieh; Meshkini, Azadeh |
Report |
Mar 1, 2009 |
4066 |
| New cytotoxic drug guidelines. |
|
Brief article |
Nov 1, 2008 |
126 |
| When human data are lacking. |
Briggs, Gerald G. |
|
Sep 1, 2008 |
780 |
| Treatment of gastro-oesophageal cancers: the need for international co-operation. |
Wong, Rachel; Cunningham, David |
Editorial |
Sep 1, 2008 |
1016 |
| Why do nurses resist safe-handling behaviors? |
Wujcik, Debra M. |
Editorial |
Aug 1, 2008 |
472 |
| Presidential campaign plans for universal health insurance: what they should cover--and won't Part 2. |
Cohen, Marcus A. |
|
Jul 1, 2008 |
3426 |
| Roche Holding AG, the world's biggest maker of tumor drugs, said a late-stage study showed its Herceptin medicine helped slow the spread of breast cancer when combined with its chemotherapy treatment Xeloda. |
|
Brief article |
Jun 9, 2008 |
186 |
| Targeted therapies in breast cancer. |
Peck, Rahul; Kularatne, Bihani; O'Brien, Ciara |
Report |
Jun 1, 2008 |
3839 |
| Study clarifies role of antioxidants during radiation. |
Moss, Ralph W. |
|
May 1, 2008 |
2316 |
| Drugs to treat age-related macular degeneration compared in trial. |
|
|
Mar 1, 2008 |
348 |
| Prognostic and predictive molecular markers in colorectal cancer: inhibition of the epidermal growth factor receptor. |
Stohlmacher, Jan |
|
Mar 1, 2008 |
2117 |
| Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma: a randomized phase III trial. |
Rougier, Philippe |
|
Mar 1, 2008 |
1352 |
| 21-gene assay predicts recurrence in node-positive breast Ca. |
Sullivan, Michele G. |
|
Feb 1, 2008 |
622 |
| Novel anticancer agents have autoimmune toxicities. |
Jancin, Bruce |
|
Feb 1, 2008 |
563 |
| How much abuse should cancer patients have to take? |
Faloon, William |
|
Nov 1, 2007 |
5131 |
| Novel cancer drug shows promise. |
Kiefer, Dale |
Brief article |
Oct 1, 2007 |
160 |
| Genotype-specific dosing may improve tolerance and anticancer activity. |
McBride, Deborah |
Brief article |
Sep 1, 2007 |
307 |
| Panitumumab with irinotecan/leucovorin/5-fluorouracil for first-line treatment of metastatic colorectal cancer. |
Carrato, Alfredo; Guillen-Ponce, Carmen |
|
Sep 1, 2007 |
1374 |
| Straight to the tumour. |
|
Reprint |
Jul 1, 2007 |
185 |
| HER2-directed therapies. |
Crabb, Simon J.; Chia, Stephen K. |
|
Jun 1, 2007 |
6544 |
| Angiogenesis and breast cancer. |
Gillmore, Roopinder; Miles, David |
|
Jun 1, 2007 |
2456 |
| Coding Zoladex depends on the patient's condition. |
Witt, Melanie |
Brief article |
May 1, 2007 |
181 |
| Focused ultrasound hones breast cancer ablation. |
Jancin, Bruce |
|
Apr 1, 2007 |
448 |
| Conventional treatments: chemotherapy--a medical 'solution'. |
Bridgman, Karen E. |
|
Mar 22, 2007 |
5475 |
| Inhibitory effect of pirfenidone on glioblastoma cell lines: implications for treatment of neurofibromatosis. |
Krishnan, Sunil; Goble, Jennie M.; Frederick, Lori A.; James, C. David; Uhm, Joon H.; Kaufmann, Scot |
Clinical report |
Mar 1, 2007 |
4297 |
| Genentech Inc's. |
|
Brief article |
Feb 26, 2007 |
156 |
| Drug-drug interactions in oncology: implications for general practice. |
|
Clinical report |
Feb 1, 2007 |
2090 |
| Effects of Hydrocotyle sibthorpioides extract on transplanted tumors and immune function in mice. |
Yu, Farong; Yu, Fahong; McGuire, P.M.; Li, R.; Wang, R. |
Clinical report |
Feb 1, 2007 |
4012 |
| Talactoferrin Alpha receives fast-track designation for the treatment of non-small cell lung cancer. |
McBride, Deborah |
|
Jan 1, 2007 |
603 |
| Bacteria-based immune therapy targets liver metastases. |
|
Brief article |
Jan 1, 2007 |
255 |
| IND for MDX-1401. |
|
Brief article |
Jan 1, 2007 |
170 |
| Temsirolimus extends survival in renal cancer. |
Lowry, Fran |
|
Oct 15, 2006 |
376 |
| Testosterone fails to rev cancer survivors libido. |
Tanzola, Melinda |
|
Sep 15, 2006 |
276 |
| New antiangiogenesis agents fight lung cancer. |
MacNeil, Jane Salodof |
|
Sep 1, 2006 |
770 |
| High-dose tretinoin safe for skin ca prevention: irritation caused by the higher dose is usually mild and transient. |
Goldman, Erik |
Drug overview |
Jul 15, 2006 |
628 |
| Circulating tumor cells predict outcome in metastatic breast Ca. |
|
|
Apr 1, 2005 |
450 |
| New Rx for chemotherapy-induced oral mucositis. |
Jancin, Bruce |
|
Apr 1, 2005 |
613 |
| Safer way to curb local breast Ca recurrences. |
Jancin, Bruce |
|
Mar 15, 2005 |
595 |
| Breast cancer surgery seems unaffected by menstrual timing. |
|
|
Mar 15, 2005 |
337 |
| Rash often seen with new class of cancer drugs. |
Kirn, Timothy F. |
|
Mar 1, 2005 |
694 |
| Low calcium, vitamin D intake rampant in breast cancer patients. |
|
|
Mar 1, 2005 |
498 |
| Refined chemo helps in ER-negative breast Ca. |
Jancin, Bruce |
|
Mar 1, 2005 |
584 |
| Oral glutamine curbs radiation dermatitis in breast cancer patients. |
|
|
Mar 1, 2005 |
628 |
| Adjunctive chemotherapy adds benefit to tamoxifen in node-positive breast Ca. |
|
|
Mar 1, 2005 |
298 |
| A chord-based method for computing alpha particle doses to the skeleton. |
Frederick, Steven; Jokisch, Derek W. |
|
Jan 1, 2005 |
138 |
| Erlotinib, gefitinib nip lung cancer mortality. |
Goldman, Erik L. |
|
Sep 1, 2004 |
578 |
| Epoetin beats darbepoetin for colorectal cancer; more cost effective. |
Finn, Robert |
Brief Article |
Jun 15, 2004 |
283 |
| FDA approves cetuximab for colorectal cancer: target therapy for metastatic disease. |
Mechcatie, Elizabeth |
|
Mar 15, 2004 |
900 |
| Fighting cancer with folate. |
|
|
Jul 1, 2002 |
410 |
